Edwards Lifesciences (EW) Inventory (2009 - 2026)

Edwards Lifesciences has reported Inventory for 18 years, with the latest figure at $1.1 billion in Q2 2026.

• On a quarterly basis, Inventory fell 0.92% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 0.92% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 3.63% from the prior year.
• Inventory was $1.1 billion for Q2 2026 at Edwards Lifesciences, up from $1.1 billion in the prior quarter.
• The five-year high for Inventory was $1.2 billion in Q1 2024, with the low at $730.6 million in Q1 2022.
• Average Inventory over 5 years is $1.0 billion, with a median of $1.1 billion recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Inventory soared 36.24% in 2023, then decreased 7.74% in 2025.
• Over 5 years, Inventory stood at $875.5 million in 2022, then advanced by 3.2% to $903.5 million in 2023, then advanced by 20.28% to $1.1 billion in 2024, then climbed by 3.63% to $1.1 billion in 2025, then increased by 0.44% to $1.1 billion in 2026.
• The last three Inventory figures came in at $1.1 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.